TABLE 2.
Factors associated with the PACT‐Q Convenience score
Factor | RC (95% CI) | P value |
---|---|---|
Convenience (constant) | 96.58 (95.25 to 97.91) | |
Negative sense of security | −1.29 (−2.16 to −0.41) | .004 |
Bleeding | ||
No bleeding | Reference | |
Without consultation | −0.40 (−2.67 to 1.86) | .73 |
With evaluation by physician | −3.43 (−5.49 to −1.37) | .001 |
With hospitalization | −0.39 (−3.32 to 2.54) | .80 |
Thrombotic event | 1.05 (−1.70 to 3.80) | .45 |
Gastrointestinal side effects | −1.92 (−3.07 to −0.76) | .001 |
Previous use of VKA and/or APT | −0.76 (−1.52 to 0.01) | .053 |
DOAC frequency | ||
Once daily | Reference | |
Twice daily | −0.20 (−1.17 to 0.77) | .69 |
DOAC nonadherence | −1.42 (−2.32, −0.51) | .002 |
Intervention at dentist | ||
No intervention | Reference | |
Intervention with DOAC adjustment | −1.39 (−3.06 to 0.28) | .10 |
Intervention without DOAC adjustment | −0.44 (−1.29 to 0.40) | 0.31 |
Abbreviations: APT, antiplatelet therapy; CI, confidence interval; DOAC, direct oral anticoagulant; PACT‐Q, Perception of Anticoagulant Treatment Questionnaire; RC, regression coefficient; VKA, vitamin K antagonist.
n = 796, R square =0.090, analysis adjusted for sex, age, and socioeconomic status.